Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Long-Term Liabilities (Tables)

v3.20.4
Accrued Expenses and Long-Term Liabilities (Tables)
 6 Months Ended
Jun. 30, 2020
Accrued Expenses And Long-term Liabilities  
Schedule of Other Accrued Expenses

Other accrued expenses consisted of the following as of June 30, 2020 and December 31, 2019:

 

    June 30, 2020     December 31, 2019  
    (unaudited)        
Accrued royalties   $ 2,237     $ 1,934  
Contingent consideration     654       502  
Medicare payment advance     2,066       -  
Operating lease liability     1,171       1,321  
Financing lease liability     150       184  
Deferred revenue     209       457  
Payable to CGI     -       888  
Accrued sales and marketing - diagnostics     103       197  
Accrued lab costs - diagnostics     125       163  
Accrued professional fees     1,196       1,399  
Taxes payable     311       403  
Unclaimed property     565       565  
All others     950       1,463  
Total other accrued expenses   $ 9,737     $ 9,476  
Schedule of Long Term Liabilities

Long-term liabilities consisted of the following as of June 30, 2020 and December 31, 2019:

 

    June 30, 2020     December 31, 2019  
    (unaudited)        
Warrant liability   $ 33     $ 82  
Uncertain tax positions     4,210       4,081  
Deferred revenue     239       269  
Other     75       141  
Total other long-term liabilities   $ 4,557     $ 4,573